| Trial ID: | L0909 |
| Source ID: | IRCT2013071313984N1
|
| Associated Drug: |
Coenzyme Q10
|
| Title: |
Effect of Coenzyme Q10 on serum levels of inflammatory markers, liver enzymes, leptin and adiponectin in patients with non alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty liver Disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Intervention group: daily consumption of 100 milligram coenzyme Q10 supplement for 3 months. Intervention 2: Control group: daily consumption of 100 milligram starch for 3 months.;Treatment - Drugs;Placebo;Intervention group: daily consump
|
| Outcome Measures: |
Aspartate aminotransferase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Photometric.;Alanine aminotransferase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Photometric.;Interlukine-6. Timepoint: Before intervention and 3 months after intervention. Method of measurement: ELISA.;Hs-CRP. Timepoint: Before intervention and 3 months after intervention. Method of measurement: ELISA.;Gamma-glutamyl transpeptidase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Photometric.;TNF-a. Timepoint: Before intervention and 3 months after intervention. Method of measurement: ELISA.;Adiponectin. Timepoint: Before intervention and 3 months after intervention. Method of measurement: ELISA.;Leptin. Timepoint: Before intervention and 3 months after intervention. Method of measurement: ELISA.;Fasting blood sugar. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Photometric.;LDL-C. Timepoint: Before intervention and 3 months after intervention. Method of measurement: undirected method with Friedewald.;Total cholestrol. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Photometric.;HDL-C. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic.;Triglyciride. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Photometric.;VLDL. Timepoint: Before intervention and 3 months after intervention. Method of measurement: TG/5.Hip circumference. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Meter.;Waist circumference. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Meter.;Blood pressure. Timepoint: Before intervention and 3 month after intervention. Method of measurement: Blood Pressure Monitor.;Body mass index. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Body weight in kilograms divided by height squared in meters.;Body weight. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Digital scale.
|
| Sponsor/Collaborators: |
Vice chancellor for research, Ahvaz Jondishapur University Of Medical Sciences
|
| Gender: |
All
|
| Age: |
19 years59 years
|
| Phases: |
Phase 2
|
| Enrollment: |
40
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
18/12/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/13691
|
